Table 2.
Adverse Events Occurring by Day 42
| Adverse Event | CP7 n = 165 |
CP14 n = 164 |
DP7 n = 162 |
DP14 n = 163 |
P-Valuea |
|---|---|---|---|---|---|
| Abdominal pain, n (%) | 44 (33%) | 35 (27%) | 25 (20%) | 13 (10%) | .001b |
| Anemia, n (%) | 12 (7%) | 17 (10%) | 20 (12%) | 18 (11%) | .479 |
| Nausea or vomiting, n (%) | 12 (7%) | 10 (6%) | 5 (3%) | 9 (6%) | .404 |
| Dizziness, n (%) | 15 (9%) | 22 (13%) | 18 (11%) | 29 (18%) | .106 |
| Headache, n (%) | 15 (9%) | 15 (9%) | 18 (11%) | 21 (13%) | .635 |
| Fatigue, n (%) | 11 (7%) | 9 (6%) | 6 (4%) | 10 (6%) | .668 |
aχ2 used for significance testing unless otherwise noted.
bAbdominal pain was significantly less in the DP14 arm compared to the other arms; logistic regression was used to compare differences between groups.